{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T20:14:18Z","timestamp":1774296858275,"version":"3.50.1"},"reference-count":58,"publisher":"American Society for Microbiology","issue":"2","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Infect Immun"],"published-print":{"date-parts":[[2005,2]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>The fucose-mannose ligand (FML) complex of<jats:italic>Leishmania donovani<\/jats:italic>is a promising vaccine candidate against murine and canine visceral leishmaniasis, and its main component is a 36-kDa nucleoside hydrolase (NH36). In this study, we tested the immune response and protection induced by the purified FML, the recombinant NH36 (rNH36), and NH36 DNA vaccines against the agents of visceral (<jats:italic>L. chagasi<\/jats:italic>) and cutaneous (<jats:italic>L. mexicana<\/jats:italic>) leishmaniasis in BALB\/c mice. Mice developed weak humoral response to the vaccines alone, except for those immunized with FML. However, all three vaccine groups presented elevated immunoglobulin G (IgG), IgG1, and IgG2a levels after infection with<jats:italic>L. chagasi<\/jats:italic>, whereas no differences were observed between vaccine and control groups after infection with<jats:italic>L. mexicana<\/jats:italic>. A strong intradermal reaction to<jats:italic>L. donovani<\/jats:italic>and<jats:italic>L. mexicana<\/jats:italic>antigens was observed in mice immunized with rNH36 or FML, whereas mice immunized with NH36 DNA only reacted against<jats:italic>L. donovani<\/jats:italic>antigens. Experimental infection of immunized mice demonstrated that FML and rNH36 induced significant protection against<jats:italic>L. chagasi<\/jats:italic>infection with reductions in parasite loads of 79%. FML also conferred partial protection against<jats:italic>L. mexicana<\/jats:italic>infection. The best protection was observed in mice immunized with the VR1012-NH36 DNA vaccine, which induced an 88% reduction in<jats:italic>L. chagasi<\/jats:italic>parasite load and a 65% reduction in<jats:italic>L. mexicana<\/jats:italic>lesion size. Fluorescence-activated cell sorting analysis indicated the DNA vaccine induced a two- to fivefold increase in gamma interferon-producing CD4<jats:sup>+<\/jats:sup>T cells, indicating a Th1-type immune response. Our results showed that the NH36 DNA vaccine induced a strong immunoprotection against visceral and cutaneous leishmaniasis, suggesting that this DNA vaccine represents a very good candidate for use against several<jats:italic>Leishmania<\/jats:italic>species.<\/jats:p>","DOI":"10.1128\/iai.73.2.812-819.2005","type":"journal-article","created":{"date-parts":[[2005,1,21]],"date-time":"2005-01-21T02:03:07Z","timestamp":1106272987000},"page":"812-819","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":90,"title":["Cross-Protective Efficacy of a Prophylactic<i>Leishmania donovani<\/i>DNA Vaccine against Visceral and Cutaneous Murine Leishmaniasis"],"prefix":"10.1128","volume":"73","author":[{"given":"Ingrid","family":"Aguilar-Be","sequence":"first","affiliation":[{"name":"Laboratorio de Parasitologi\u0301a"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renata","family":"da Silva Zardo","sequence":"additional","affiliation":[{"name":"Instituto de Microbiologia \u201cProfessor Paulo de Go\u0301es,\u201d Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edilma","family":"Paraguai de Souza","sequence":"additional","affiliation":[{"name":"Instituto de Microbiologia \u201cProfessor Paulo de Go\u0301es,\u201d Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gulnara Patri\u0301cia","family":"Borja-Cabrera","sequence":"additional","affiliation":[{"name":"Instituto de Microbiologia \u201cProfessor Paulo de Go\u0301es,\u201d Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Rosado-Vallado","sequence":"additional","affiliation":[{"name":"Laboratorio de Parasitologi\u0301a"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirza","family":"Mut-Martin","sequence":"additional","affiliation":[{"name":"Laboratorio de Inmunobiologi\u0301a, Centro de Investigaciones Regionales \u201cDr. Hideyo Noguchi,\u201d Universidad Auto\u0301noma de Yucata\u0301n, Me\u0301rida, Yucata\u0301n, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"del Rosario Garci\u0301a-Miss","sequence":"additional","affiliation":[{"name":"Laboratorio de Inmunobiologi\u0301a, Centro de Investigaciones Regionales \u201cDr. Hideyo Noguchi,\u201d Universidad Auto\u0301noma de Yucata\u0301n, Me\u0301rida, Yucata\u0301n, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clarisa Beatriz","family":"Palatnik de Sousa","sequence":"additional","affiliation":[{"name":"Instituto de Microbiologia \u201cProfessor Paulo de Go\u0301es,\u201d Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Dumonteil","sequence":"additional","affiliation":[{"name":"Laboratorio de Parasitologi\u0301a"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","first-page":"185","year":"1986","unstructured":"Alexander, J., and J. M. Blackwell. 1986. The immunological significance of genetically determined cross reactivity between taxonomically distinct Leishmania species, p. 185-191. In J. A. Rioux (ed.), Leishmania, taxonomie et phylogen\u00e8se: application \u00e9co-\u00e9pidemiologiques. Institut M\u00e9diterran\u00e9en d'Etudes Epid\u00e9miologiques et Ecologiques, Montpellier, France.","journal-title":"Leishmania, taxonomie et phylogen\u00e8se: application \u00e9co-\u00e9pidemiologiques"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-4894(78)90049-8"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1986.35.732"},{"key":"e_1_3_2_5_2","first-page":"137","volume":"30","year":"2000","unstructured":"Bebars, M. A., A. O. el Serougi, K. M. Makled, E. M. Mikhael, M. M. Abou Gamra, M. el Sherbiny, A. W. Mohareb, and E. A. Mohammed. 2000. An experimental vaccine providing heterologous protection for Leishmania species in murine model. J. Egypt. Soc. Parasitol.30:137-156.","journal-title":"J. Egypt. Soc. Parasitol."},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(02)00294-3"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2003.11.039"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1999.61.296"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.71.11.6270-6278.2003"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.70.6.2828-2836.2002"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1998.58.444"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0035-9203(02)90044-1"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-1119(01)00768-5"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(00)00339-X"},{"key":"e_1_3_2_15_2","first-page":"267","volume":"45","year":"1992","unstructured":"Desjeux, P. 1992. Human leishmaniases: epidemiology and public health aspects. World Health Stat. Quart.45:267-275.","journal-title":"World Health Stat. Quart."},{"key":"e_1_3_2_16_2","doi-asserted-by":"crossref","unstructured":"Dumonteil E. D. McMahon-Pratt and V. Price. 2001. Report on the fourth TDR\/IDRI meeting on second-generation vaccines against leishmaniasis 1 to 3 May 2001. Universidad Autonoma de Yucatan Yucatan Mexico. Document TDR\/PDR\/LEISH\/VAC\/01.1.","DOI":"10.32776\/revbiomed.v13i1.296"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(02)00769-7"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1006\/expr.1996.4117"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi952998u"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/4000"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.186.7.1137"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.165.2.915"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/21.3.701"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0001-706X(98)00057-6"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.76.13.6453-6459.2002"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)03128-7"},{"key":"e_1_3_2_27_2","first-page":"29","volume":"80","year":"1977","unstructured":"Lainson, R., and J. J. Shaw. 1977. Leishmaniasis in Brazil: XII. Observations on cross-immunity in monkeys and man infected withLeishmania mexicana mexicana, L. m. amazonensis, L. braziliensis braziliensis, L. b. guyanensis and L. b. panamensis. J. Trop. Med. Hyg. 80:29-35.","journal-title":"Observations on cross-immunity in monkeys and man infected with"},{"key":"e_1_3_2_28_2","first-page":"71","volume":"94","year":"1999","unstructured":"Lima, H. C., G. K. DeKrey, and R. G. Titus. 1999. Resolution of an infection with Leishmania brasiliensis confers complete protection to a subsequent challenge with Leishmania major in BALB\/c mice. Mem. Inst. Oswaldo Cruz94:71-76.","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-4758(00)01637-9"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.69.8.4719-4725.2001"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.166.8.5122"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(17)42957-7"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0001-706X(99)00055-8"},{"key":"e_1_3_2_34_2","first-page":"304","volume":"2","year":"1995","unstructured":"Okongo-Odera, E. A., E. S. Mitema, D. K. Koech, and A. S. Orago. 1995. Cross-reactive studies in visceral leishmaniasis: comparison of antigens of some Leishmania species in Kenya. Afr. J. Health Sci.2:304-308.","journal-title":"Afr. J. Health Sci."},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-4017(95)00788-6"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.57.3.754-763.1989"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00928181"},{"key":"e_1_3_2_38_2","first-page":"290","volume":"46","year":"1994","unstructured":"Palatnik de Sousa, C. B., M. M. Bunn Moreno, E. Paraguai de Souza, and R. Borojevic. 1994. Vaccination with the FML antigen (fucose-mannose ligand) of Leishmania donovani protects hamsters from experimental visceral leishmaniasis. J. Bras. Soc. Adv. Sci.46:290-296.","journal-title":"J. Bras. Soc. Adv. Sci."},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(95)90022-5"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1590\/S0037-86821996000200008"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(01)00031-7"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0001-706X(98)00100-4"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.4.2118"},{"key":"e_1_3_2_44_2","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.4049\/jimmunol.150.6.2322","volume":"150","year":"1993","unstructured":"Rachamim, N., and C. L. Jaffe. 1993. Pure protein from Leishmania donovani protects mice against both cutaneous and visceral leishmaniasis. J. Immunol.150:2322-2331.","journal-title":"J. Immunol."},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(02)00189-5"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(01)00081-0"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1590\/S0074-02762000000500022"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1590\/S0074-02762001000100002"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-6851(02)00010-5"},{"key":"e_1_3_2_50_2","unstructured":"Santos W. R. 2002. Effect of the FML-vaccine on the tegumentar and visceral experimental murine leishmaniaisis: comparative ananlysis of adjuvants p. 123-128. Ph.D. thesis. Instituto de Microbiologia \u201cProf. Paulo de G\u00f3es \u201d Universidad Federal do Rio de Janeiro Rio de Janeiro Brazil."},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(02)00444-9"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(99)00058-4"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1038\/35021239"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.68.9.4986-4991.2000"},{"key":"e_1_3_2_55_2","first-page":"573","volume":"97","year":"2002","unstructured":"Silva, C. L., V. L. Bonato, V. M. Lima, L. H. Faccioli, and S. C. Leao. 2002. Characterization of the memory\/activated T cells that mediate the long-lived host response against tuberculosis after bacillus Calmette-Guerin or DNA vaccination. Immunol.97:573-581.","journal-title":"Immunol."},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(98)00075-9"},{"key":"e_1_3_2_57_2","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.4049\/jimmunol.160.8.3949","volume":"160","year":"1998","unstructured":"Sjolander, A., T. M. Baldwin, J. M. Curtis, and E. Handman. 1998. Induction of a Th1 immune response and simultaneous lack of activation of a Th2 response are required for generation of immunity to leishmaniasis. J. Immunol.160:3949-3957.","journal-title":"J. Immunol."},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.160197797"},{"key":"e_1_3_2_59_2","first-page":"173","volume":"84","year":"1995","unstructured":"Xu, D., and F. Y. Liew. 1995. Protection against leishmaniasis by injection of DNA encoding a major surface glycoprotein, gp63, of Leishmania major.Immunology84:173-176.","journal-title":"Immunology"}],"container-title":["Infection and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.73.2.812-819.2005","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.73.2.812-819.2005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T19:08:27Z","timestamp":1682968107000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/IAI.73.2.812-819.2005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":58,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["10.1128\/IAI.73.2.812-819.2005"],"URL":"https:\/\/doi.org\/10.1128\/iai.73.2.812-819.2005","relation":{},"ISSN":["0019-9567","1098-5522"],"issn-type":[{"value":"0019-9567","type":"print"},{"value":"1098-5522","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,2]]},"assertion":[{"value":"2004-07-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2004-10-08","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2005-02-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}